「The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-derived iPS cells」の関連論文
-
Novel and efficient method for culturing patient-derived gastric cancer stem cells
-
Glycoprotein NMB functions with growth factor signaling to induce tumorigenesis in breast cancer cells
-
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
-
Gold Nanoparticles Enhance the Tumor Growth-Suppressing Effects of Cetuximab and Radiotherapy in Head and Neck Cancer In Vitro and In Vivo
-
SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization
-
Inhibition of Dopamine Receptor D1 Signaling Promotes Human Bile Duct Cancer Progression via WNT signaling
-
Distinct but interchangeable subpopulations of colorectal cancer cells with different growth fates and drug sensitivity
-
Characterization and reduction of non-endocrine cells accompanying islet-like endocrine cells differentiated from human iPSC
-
Urinary MicroRNA-Based Diagnostic Model for Central Nervous System Tumors Using Nanowire Scaffolds
-
Studies on DNA methylation changes in canine malignant melanoma [an abstract of entire text]
-
Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer
-
Immunohistochemical assessment of sex-determining region Y (SRY)-related high mobility group (HMG)-box 2 (Sox2) and Krüppel-like factor 4 (Klf4) in ameloblastomas
-
IFI16 Induced by Direct Interaction between Esophageal Squamous Cell Carcinomas and Macrophages Promotes Tumor Progression via Secretion of IL-1α
-
Pancreatic RECK inactivation promotes cancer formation, epithelial-mesenchymal transition, and metastasis
-
An autopsy case of primary gliosarcoma with multiple extracranial metastases: pathology after administration of bevacizumab and genetic profile
-
Blockage of retinoic acid signaling via RARγ suppressed the proliferation of pancreatic cancer cells by arresting the cell cycle progression of the G1-S phase
-
Design of Novel Targeted Co-delivery System for Combined Chemotherapy and Gene Therapy of Hepatocellular Carcinoma [an abstract of entire text]
-
Cell-to-cell contact-mediated regulation of tumor behavior in the tumor microenvironment.
-
STAT3 induces hypoxic preconditioning against oxidative stress in neural stem cells
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
HIV-1 tracing method of systemic viremia in vivo using an artificially mutated virus pool
-
PBK expression predicts favorable survival in colorectal cancer patients
-
Differential Roles of Dendritic Cells in Expanding CD4 T Cells in Sepsis
-
CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence
-
Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles
-
Predicting the presence of breast cancer using circulating small RNAs, including those in the extracellular vesicles
-
Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma
-
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid Leukemia
-
Studies on Peripheral Blood mMDSC Based-Biomarker Exploration and a Novel Therapeutic Agent for Cancer Immunotherapy
-
Cancer-specific targeting of taurine upregulated gene 1 enhances the effects of chemotherapy in pancreatic cancer
-
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism
-
Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
-
Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans (本文)
-
Transposon delivery for CRISPR-based loss-of-function screen in mice identifies NF2 as a cooperating gene involved with the canonical WNT signaling molecular class of hepatocellular carcinoma
-
Glycan profile of signet ring cell gastric cancer and potential applicability of lectin drug conjugate therapy
-
大気圧酸素プラズマ照射によるT細胞の活性制御に関する研究
-
Local hyperthermia with built-in endoscopy for radioresistant cervical cancer: a case series
-
Basis research and development of DNA-targeted radio-platinum agents for Auger electron cancer therapy
-
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling.
-
Efficacy of the Novel Tubulin Polymerization Inhibitor PTC-028 for Myelodysplastic Syndrome
-
Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma
-
Biological and clinical significance of the YKL-40/osteopontin–integrin β4–p70S6K axis induced by macrophages in early oesophageal squamous cell carcinoma
-
An HSP90 inhibitor overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIs
-
Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA
-
Tenascin C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation
-
How to improve outcomes of elderly patients with acute myeloid leukemia: era of excitement
-
Studies on the pathological mechanism of alopecia areata in C3H/HeJ mouse model
-
The EZH2 inhibitor tazemetostat upregulates the expression of CCL17/TARC in B-cell lymphoma and enhances T-cell recruitment
-
The effect of gemcitabine on cell cycle arrest and microRNA signatures in pancreatic cancer cells
-
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells